Big conductance calcium-activated potassium channel openers control spasticity without sedation. (2017)
Attributed to:
Biomedical Catalyst – Drug product production, clinical support studies, and phase 1 trial of a new MS drug
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.13889
PubMed Identifier: 28677901
Publication URI: http://europepmc.org/abstract/MED/28677901
Type: Journal Article/Review
Volume: 174
Parent Publication: British journal of pharmacology
Issue: 16
ISSN: 0007-1188